Matsuno Takahiro, Okumura Toshiya
Nephrology, Komatsu Sophia Hospital, Komatsu, JPN.
Nephrology, Tonami General Hospital, Tonami, JPN.
Cureus. 2023 May 30;15(5):e39737. doi: 10.7759/cureus.39737. eCollection 2023 May.
Anti-glomerular basement membrane (anti-GBM) disease has one of the worst prognoses of nephritis and is rarely associated with other forms of glomerulonephritis. In this report, we present the case of a 76-year-old man who developed anti-GBM disease four months after being diagnosed with IgA nephropathy (IgAN). To our knowledge, although there have been several reports of IgAN combined with anti-GBM disease, there have been no cases in which we were able to confirm that the anti-GBM antibody titer changed from negative to positive over the disease course. This case suggests that even patients with previously diagnosed chronic glomerulonephritis, including IgAN, and an unusually rapid clinical course should be evaluated for the presence of autoantibodies to exclude overlapping autoimmune diseases.
抗肾小球基底膜(anti-GBM)病是肾炎中预后最差的疾病之一,很少与其他形式的肾小球肾炎相关。在本报告中,我们介绍了一例76岁男性患者,他在被诊断为IgA肾病(IgAN)四个月后发生了抗GBM病。据我们所知,虽然有几篇关于IgAN合并抗GBM病的报道,但尚无病例能证实抗GBM抗体滴度在病程中从阴性变为阳性。该病例表明,即使是先前诊断为慢性肾小球肾炎(包括IgAN)且临床病程异常迅速的患者,也应评估自身抗体的存在,以排除重叠的自身免疫性疾病。